CPTP 4.1-4.4 Flashcards
What is required before a drug can be tested for the first time in man studies
In preclinical development phase. pharmaceutical and analytical studies. Safety pharmacology, toxicology studies in at least 2 preclinical species. drug metabolism and distribution.
What is phase 1 clinical development
First use in humans - healthy volunteers (or patient volunteers in high risk drugs). Confirm pharmacokinetics established from animal studies. find dose limiting toxicity level.
effects of single/multiple dosing. effects of food. potential drug interactions
What is phase 2 clinical development
wider use in patient groups. establish potential therapeutic value, determine effective dose range, adverse effects
What is phase 3 clinical development
Large scale trials in patient groups, often international. compare with placebo and other tx already established. establish clinical benefit. common adverse effects at therapeutic doses
What happens after phase 3 clinical development
approval and launch - licencing process
criteria used to make licencing decisions
quality (contains active ingredients at stated dose, bioavailability acceptable), efficacy (positive effect in affected patients, beneficial), safety (relative absence of harm, no such thing as absolute safety). cost is not taken into account.
is cost taken into account when licencing decisions are made
no
For which medicines is a central procedure (e.g. considered by European Medicines Agency) compulsory?
HIV, cancer, diabetes, neurodegenerative disease, AI, viral disease tx
tx derived from biotech processes (genetic engineering)
gene therapy etc
what does licencing mean for the doctor
they are protected from litigation if the medicine is used in accordance with SPC (summary of product characteristics - part of product licence)
how long is a standard patent
20 years
market lifespan of drugs
5-15 years as takes 10-15y to develop drug and patent only lasts 20 years before generics can be marketed
What is ABPI
Association of British Pharmaceutical Industry
What is an ADR
Any response to a drug which is noxious, unintended and occurs at doses used for prophylaxis, diagnosis or therapy
What is a medication error
any preventable event that may cause or lead to inappropriate medication use or patient harm while the medication is in the control of health professional, patient or consumer
benzodiazepine antagonist
flumezenil
NICE definition of compliance
the extent to which patient’s behaviour matches the prescribers recommendation. term being used less as implies lack of patient involvement
NICE definition of adherence
the extent to which the patient’s action or behaviour matches the agreed recommendations from the prescriber
NICE definition of concordance
relationship between the patient and the prescriber and the degree to which they agree about the treatment
E.g.s of drugs where monitoring plasma drug conc is appropriate as there is a good relation between plasma conc and pharmacological or toxic effect
lithium, carbamazepine
e.g. of a drug where dose and plasma conc relation is unpredictable
phenytoin
what is considered to be the steady state concentration in general
5 half lives unless loading dose used
drugs with a narrow TI
digoxin, lithium, methotrexate, carbamazepine, ciclosporin, phenytoin, sulphonylureas, theophylline, warfarin
why is free phenytoin sometimes useful
it is highly albumin bound, and can be displaced by other drugs
ABCDE classification of ADRs - explanation of each
Augmented - predictable, dose-related
Bizarre - not dose-related, not predictable
Chronic - variable, occur with prolonged duration tx but not with short-duration
Delayed - variable, occur some time after discontinuation of tx
End of tx - effects occur on withdrawal
e.g. of an augmented ADR
nitrates causing headaches
e.g. of a bizarre ADR
penicillin anaphylaxis, halothane hepatitis, agranulocytosis with chloramphenicol (BM failure)
e.g. of a chronic ADR
osteoporosis with steroids, tardive dyskinesia with antipsychotics
e.g. of a delayed ADR
drug induced cancers, drug induced foetal anomalies